Privia Health Group Inc’s recently made public that its EVP & Chief Financial Officer Mountcastle David unloaded Company’s shares for reported $69889.0 on Apr 02 ’24. In the deal valued at $17.77 per share,3,933 shares were sold. As a result of this transaction, Mountcastle David now holds 262,279 shares worth roughly $4.93 million.
Then, Sullivan William M sold 400 shares, generating $9,208 in total proceeds. Upon selling the shares at $23.02, the Director now owns 5,445,018 shares.
Before that, Sullivan William M sold 7,115 shares. Privia Health Group Inc shares valued at $163,858 were divested by the Director at a price of $23.03 per share. As a result of the transaction, Sullivan William M now holds 5,445,418 shares, worth roughly $102.37 million.
Citigroup initiated its Privia Health Group Inc [PRVA] rating to a Buy in a research note published on April 22, 2024; the price target was $25. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Equal weight”‘ rating. BofA Securities revised its rating on February 22, 2024. It rated PRVA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PRVA
On Tuesday, Privia Health Group Inc [NASDAQ:PRVA] saw its stock jump 4.16% to $18.80. Over the last five days, the stock has gained 6.27%. Privia Health Group Inc shares have fallen nearly -18.37% since the year began. Nevertheless, the stocks have fallen -28.33% over the past one year. While a 52-week high of $30.15 was reached on 01/02/24, a 52-week low of $17.54 was recorded on 04/02/24. SMA at 50 days reached $20.02, while 200 days put it at $22.56. A total of 0.85 million shares were traded, compared to the trading of 0.66 million shares in the previous session.
Levels Of Support And Resistance For PRVA Stock
The 24-hour chart illustrates a support level at 18.09, which if violated will result in even more drops to 17.39. On the upside, there is a resistance level at 19.26. A further resistance level may holdings at 19.73. The Relative Strength Index (RSI) on the 14-day chart is 48.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.24%. Stochastics %K at 41.24% indicates the stock is a holding.
The most recent change occurred on December 06, 2023 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $27 price target.
